Nomura Holdings
ARQT icon

Nomura Holdings’s Arcutis Biotherapeutics ARQT Stock Holding History

Nomura Holdings’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,600
Closed -$492K – 1445
2022
Q4 		$492K Sell
33,600
-26,400
-44% -$461K ﹤0.01% 979
2022
Q3 		$1.15M Sell
60,000
-24,300
-29% -$551K ﹤0.01% 917
2022
Q2 		$1.83M Buy
+84,300
New +$1.73M 0.01% 817

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's ARQT Position: Q1 2026 in Review

Nomura Holdings opened a new position in Arcutis Biotherapeutics (ARQT) in Q1 2026: 22,943 shares worth $541K. The stake represents ﹤0.01% of the portfolio and ranks #1341 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in ARQT as recently as Q4 2022.

Nomura Holdings first reported a position in ARQT in Q2 2022 and has held it in 4 quarters since. 269 funds tracked by Wall St. Rank hold ARQT as of Q1 2026.

  • Nomura Holdings held 22,943 shares of Arcutis Biotherapeutics worth $541K as of Q1 2026.
  • Arcutis Biotherapeutics was a new Nomura Holdings position in Q1 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1341 holding.
  • Nomura Holdings first reported a position in Arcutis Biotherapeutics in Q2 2022 and has held it in 4 quarters since.
  • 269 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.